Guide du CDC sur l'Hantavirus : Surveillance, Notification et Réponse Croisière 2026

The US Centers for Disease Control and Prevention is the primary federal authority for hantavirus surveillance, laboratory confirmation, and clinical guidance in the United States. When a suspected case appears in an American hospital, the path from bedside suspicion to a confirmed entry in the national notifiable diseases system runs through the CDC. In 2026, that machinery is being tested in a way it has not been in three decades: not by a domestic rodent-exposure cluster, but by the international fallout of the MV Hondius Andes-virus outbreak and the quarantine of US passengers in Nebraska.

1. The CDC's role in hantavirus surveillance

Hantavirus pulmonary syndrome (HPS) has been a nationally notifiable condition in the United States since 1993, the year the Four Corners outbreak introduced Sin Nombre virus to American clinicians. Since then, every confirmed case has been reported by state health departments to the CDC through the National Notifiable Diseases Surveillance System (NNDSS). The CDC aggregates, deduplicates, and publishes counts by state and hantavirus species.

The agency's Division of Vector-Borne Diseases, based in Fort Collins, Colorado, maintains the reference laboratory for hantaviruses and other rodent- and arthropod-borne pathogens. It provides confirmatory testing for state public-health labs, characterizes viral genomes, and supports outbreak investigations domestically and, on request, internationally.

2. The CDC case definition for HPS

Before a hospital case becomes a counted case, it has to meet the CDC's case definition, which was last revised before the current outbreak. There are two relevant categories:

• Person Under Investigation (PUI) — clinically compatible illness in a person with a plausible exposure, before laboratory results are available
• Confirmed case — clinically compatible illness with laboratory confirmation

The clinical criteria for HPS, summarized, require a febrile illness with bilateral diffuse interstitial edema on imaging or an adult-respiratory-distress-syndrome picture, with onset within 72 hours of hospitalization, in a previously healthy person — or, in a fatal case, an autopsy showing non-cardiogenic pulmonary edema without an alternative explanation.

Laboratory confirmation requires one of: detection of hantavirus-specific IgM, or a rising titer of IgG; positive RT-PCR for hantavirus RNA; or immunohistochemical detection of hantavirus antigen in tissue. Detail on the laboratory pathway is in our companion piece on hantavirus diagnosis.

3. CDC laboratory testing

The Vector-Borne Diseases reference lab runs both molecular and serologic assays. In practice, the first test on a suspect case is usually an IgM ELISA against a recombinant nucleocapsid antigen, which is sensitive within a few days of symptom onset. Confirmation may add IgG ELISA, immunoblot, and RT-PCR on serum or respiratory tissue. For Andes virus specifically — the species driving the MV Hondius outbreak — the CDC has historically relied on collaboration with South American reference labs because the virus is uncommon in US specimens.

State labs in the Laboratory Response Network can run initial serology, but isolates and unusual results are forwarded to the CDC for sequencing. In an outbreak with cross-border movement, this matters: confirming that a US passenger's strain matches the MV Hondius cluster requires sequence-level comparison, not just a positive antibody result.

4. CDC and the 2026 MV Hondius response

The MV Hondius outbreak is the first time in the modern era that the CDC has invoked federal quarantine authority for a hantavirus exposure. The agency's response has unfolded in several stages:

• May 18, 2026 — 18 US passengers disembarking on a repatriation flight were directed to a federal quarantine station near Omaha, Nebraska, with a 21-day observation period covering the upper bound of the Andes-virus incubation window.
• Mandatory orders for two passengers who initially declined voluntary isolation. According to reporting by Healthbeat and NPR, written federal quarantine orders were issued under existing public-health authority and have been the subject of legal challenges from at least one passenger's attorney.
• Daily symptom checks and serology on day 7, day 14, and day 21, with immediate transfer to a referral hospital if any passenger develops fever plus respiratory symptoms.
• Contact tracing of seatmates on the repatriation flight and onward domestic travelers — see our methodology note on contact tracing for hantavirus for why this is unusual given that person-to-person spread is rare outside Andes virus.

5. The legal framework: quarantinable communicable diseases

US federal quarantine authority is not open-ended. It applies only to diseases on a list maintained by Executive Order — a list that historically includes cholera, diphtheria, infectious tuberculosis, plague, smallpox, yellow fever, viral hemorrhagic fevers, severe acute respiratory syndromes, and pandemic influenza.

Andes virus, as a hantavirus with documented person-to-person transmission, falls within the viral-hemorrhagic-fever framing used to justify the Nebraska orders, though several legal scholars quoted in the press have noted that the mapping is not airtight. Adding hantaviruses explicitly to the list would require a new Executive Order; in the interim, mandatory orders rest on the existing VHF authority and on the CDC's emergency powers under 42 CFR Part 70 and Part 71.

The legal challenges visible in the press are the predictable result: passengers and their counsel argue that asymptomatic exposure does not justify mandatory confinement, and the CDC argues that the case-fatality rate of HPS and the documented person-to-person transmission of Andes virus in South American clusters justifies caution.

6. CDC guidance for clinicians

For US clinicians, the CDC's standing recommendations on suspected HPS can be summarized in four points:

• Ask about exposure early in the workup of any febrile illness with non-cardiogenic pulmonary edema, including rodent contact, rural travel, and — since 2026 — any cruise ship travel through Patagonia or contact with MV Hondius passengers
• Report PUIs immediately to the local or state health department; do not wait for laboratory results before notifying public health
• Use standard, contact, and droplet precautions for suspected Andes-virus cases, which is a departure from earlier hantavirus guidance reflecting that strain's unique person-to-person transmission
• Refer early to a center capable of ECMO if cardiopulmonary deterioration appears — survival hinges on aggressive supportive care started before frank shock

Clinicians can read more on the early clinical picture in our page on hantavirus symptoms.

7. CDC guidance for travelers

For the public, the CDC's longstanding traveler guidance on hantavirus emphasizes rodent avoidance: do not sleep in rodent droppings, ventilate dusty buildings before entry, wet down contaminated surfaces with bleach solution rather than sweeping them, and seek care promptly for fever after potential exposure.

Since the MV Hondius outbreak, the CDC's travel notice for Patagonia and parts of southern Chile and Argentina has been elevated. Cruise-ship travelers are advised to inquire about rodent-control practices on board, avoid shore excursions into active outbreak zones, and report any febrile illness within 8 weeks of return — a window that matches the documented hantavirus incubation period. Our companion page on hantavirus prevention covers the day-to-day practical measures in more depth.

8. Coordination with WHO, ECDC, and state health departments

The CDC does not operate alone on an outbreak with passengers scattered across two dozen countries. In 2026, the agency has been one node in a network that includes:

• WHO — global situation reports, International Health Regulations notification, technical support to South American ministries
• ECDC — coordinated case definition and surveillance for European Union and EEA passengers
• State health departments — actual operational quarantine, contact tracing of domestic travelers, and PUI identification in US hospitals; Nebraska, California, Florida, and New York have been the most visible in the MV Hondius response
• Tribal and territorial health authorities — parallel reporting channels for Indigenous and Pacific jurisdictions

9. Recent CDC publications

The CDC's Morbidity and Mortality Weekly Report (MMWR) is the agency's primary peer-reviewed channel for outbreak communications. While we will not cite specific issues here that we have not directly verified, readers should expect MMWR coverage of the MV Hondius cluster, including descriptive epidemiology of the US passenger group once the 21-day observation period closes. The CDC website's hantavirus landing page is the canonical reference for case counts updated on a rolling basis.

10. What to take away

The CDC's role in the 2026 hantavirus story is twofold. It continues to do what it has done since 1993 — count, confirm, and communicate domestic HPS cases — and it has, for the first time, operationalized federal quarantine authority for an event with no US-origin exposure. Whichever way the legal challenges in Nebraska conclude, the agency's framing of the response is likely to shape US hantavirus policy for the next decade.